BioMed Research International

MicroRNA and Cardiovascular Disease 2016


Lead Editor

1Central South University, Changsha, China

2Stanford University, Stanford, USA

3Warsaw University of Life Sciences, Warsaw, Poland

4Chang Gung Memorial Hospital, Keelung, Taiwan

MicroRNA and Cardiovascular Disease 2016


Cardiovascular disease (CVD) is the leading cause of death and the most expensive health condition throughout the world, killing nearly 17 million people in 2011 around the world. During the past decade, there have been significant advances in our knowledge of the pathogenesis, diagnosis, and treatment in CVD. Recently, microRNAs (miRNAs) have emerged as being one of the most important gene regulators of widespread cellular function. However, we still do not have a complete understanding of the underlying mechanisms and pathological roles of miRNAs in cardiovascular tissue, whereas miRNAs represent a promising group of critical regulators of cardiovascular physiology and novel targets for prevention and treatment of CVD.

We sincerely invite researchers to contribute original research articles as well as review articles to this special issue, which will report the most recent results and progress about the involvement of miRNAs in CVD.

Potential topics include but are not limited to the following:

  • miRNAs function in CVD
  • miRNAs as biomarkers of CVD
  • miRNAs as potential therapeutic targets of CVD
  • miRNAs expression changes after common pharmaceutical or surgical treatment for CVD
  • Bioinformatics study of microRNA in CVD
BioMed Research International
 Journal metrics
See full report
Acceptance rate24%
Submission to final decision76 days
Acceptance to publication22 days
Journal Citation Indicator-
Impact Factor-

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.